ScholarLens Back to search
2010•Unpublished venueRequires access

THE CLINICAL VALUE OF COMBINED DETECTION AND ANALYSIS OF MULTI-TUMOR MARKERS IN PULMONARY CANCER DIAGNOSIS

Han Pengfei

Open publisher page 0 citations

Abstract

Objective:To evaluate the diagnostic value of multi-tumor markers detection for pulmonary cancer.Methods:The serums level of tumor markers were detected by the C-12 system in lung cancer patients with benign pulmonary disease and healthy persons.Results:The positive rate was 75.8% in lung cancer group,27.5% in benign pulmonary disease group and 8.5% in healthy group.The sensitivity of lung cancer diagnosis was 75.8% and the specificity was 91.5%.Conclusion:Multi-tumor markers protein biochip detective system possesses clinical reference value in diagnosis of lung cancer,and it is suitable to be used as an surveying tool in people with high risk of tumors.

About this research paper

What this paper is about

Objective:To evaluate the diagnostic value of multi-tumor markers detection for pulmonary cancer.Methods:The serums level of tumor markers were detected by the C-12 system in lung cancer patients with benign pulmonary disease and healthy persons.Results:The positive rate was 75.8% in lung cancer group,27.5% in benign pulmonary disease group and 8.5% in healthy group.The sensitivity of lung cancer diagnosis was 75.8% and the specificity was 91.5%.Conclusion:Multi-tumor markers protein biochip detective system possesses clinical reference value in diagnosis of lung cancer,and it is suitable to be used as an surveying tool in people with high risk of tumors.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To evaluate the diagnostic value of multi-tumor markers detection for pulmonary cancer.Methods:The serums level of tumor markers were detected by the C-12 system in lung cancer patients with benign pulmonary disease and healthy persons.Results:The positive rate was 75.8% in lung cancer group,27.5% in benign pulmonary disease group and 8.5% in healthy group.The sensitivity of lung cancer diagnosis was 75.8% and the specificity was 91.5%.Conclusion:Multi-tumor markers protein biochip detective system possesses clinical reference value in diagnosis of lung cancer,and it is suitable to be used as an surveying tool in people with high risk of tumors.

Key concepts: Lung cancer, Medicine, Cancer, Internal medicine, Pulmonary cancer, Disease, Tumor marker, Lung disease

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
THE CLINICAL VALUE OF COMBINED DETECTION AND ANALYSIS OF MULTI-TUMOR MARKERS IN PULMONARY CANCER DIAGNOSIS — Research Paper | ScholarLens